218 related articles for article (PubMed ID: 19238629)
21. Capecitabine, epirubicin and cisplatin in the treatment of oesophagogastric adenocarcinoma.
Corporaal S; Smit WM; Russel MG; van der Palen J; Boot H; Legdeur MC
Neth J Med; 2006 May; 64(5):141-6. PubMed ID: 16702612
[TBL] [Abstract][Full Text] [Related]
22. A randomised phase II study of combination chemotherapy with epirubicin, cisplatin and capecitabine (ECX) or cisplatin and capecitabine (CX) in advanced gastric cancer.
Yun J; Lee J; Park SH; Park JO; Park YS; Lim HY; Kang WK
Eur J Cancer; 2010 Mar; 46(5):885-91. PubMed ID: 20060288
[TBL] [Abstract][Full Text] [Related]
23. Trastuzumab for the treatment of HER2-positive metastatic adenocarcinoma of the stomach or gastro-oesophageal junction.
Norman G; Rice S; Spackman E; Stirk L; Danso-Appiah A; Suh D; Palmer S; Eastwood A
Health Technol Assess; 2011 May; 15 Suppl 1():33-42. PubMed ID: 21609651
[